MS Drug Tysabri's Return Endorsed (RedNova)
By Penni Crabtree, The San Diego Union-Tribune Mar. 9--A key advisory committee to the Food and Drug Administration unanimously endorsed the return of multiple sclerosis drug Tysabri to the market yesterday, making it likely that the FDA will give its final consent later this month.